- Home
- RAPT vs IAF Comparison
RAPT vs IAF Comparison
Compare RAPT & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- IAF
- Stock Information
- Founded
- RAPT 2015
- IAF 1985
- Country
- RAPT United States
- IAF United States
- Employees
- RAPT N/A
- IAF N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- IAF Finance/Investors Services
- Sector
- RAPT Health Care
- IAF Finance
- Exchange
- RAPT Nasdaq
- IAF Nasdaq
- Market Cap
- RAPT 122.9M
- IAF 127.6M
- IPO Year
- RAPT 2019
- IAF N/A
- Fundamental
- Price
- RAPT $11.74
- IAF $4.63
- Analyst Decision
- RAPT Buy
- IAF
- Analyst Count
- RAPT 5
- IAF 0
- Target Price
- RAPT $33.60
- IAF N/A
- AVG Volume (30 Days)
- RAPT 105.9K
- IAF 90.4K
- Earning Date
- RAPT 08-07-2025
- IAF 01-01-0001
- Dividend Yield
- RAPT N/A
- IAF 11.44%
- EPS Growth
- RAPT N/A
- IAF N/A
- EPS
- RAPT N/A
- IAF N/A
- Revenue
- RAPT N/A
- IAF N/A
- Revenue This Year
- RAPT N/A
- IAF N/A
- Revenue Next Year
- RAPT N/A
- IAF N/A
- P/E Ratio
- RAPT N/A
- IAF N/A
- Revenue Growth
- RAPT N/A
- IAF N/A
- 52 Week Low
- RAPT $5.67
- IAF $3.60
- 52 Week High
- RAPT $26.56
- IAF $4.59
- Technical
- Relative Strength Index (RSI)
- RAPT 58.44
- IAF 66.53
- Support Level
- RAPT $10.20
- IAF $4.57
- Resistance Level
- RAPT $13.50
- IAF $4.54
- Average True Range (ATR)
- RAPT 1.01
- IAF 0.04
- MACD
- RAPT -0.05
- IAF 0.01
- Stochastic Oscillator
- RAPT 77.46
- IAF 91.70
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.